Filing Flows › Janux Therapeutics (JANX) › How it makes money
How Janux Therapeutics (JANX) makes money
Janux Therapeutics (JANX) made $9.3M of revenue in the third quarter 2026 (Q3 2026), -7% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $9.3M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $9.3M | -7% |
| Q2 2026 | $10.3M | — |
| Q1 2026 | $3.7M | — |
| Q3 2025 | $10.0M | 23× |
From Janux Therapeutics' 10-Q filed Nov 5, 2026 (on EDGAR).
Questions
How does Janux Therapeutics make money?
Janux Therapeutics (JANX) made $9.3M of revenue in the third quarter 2026 (Q3 2026), -7% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.